Open Access
Subscription Access
Prediction of Prostate Cancer Using Boosting Technique
Abstract
There are many diseases that are associated with humans, but some diseases might be associated with only males or only females. This paper shows and discusses the disorder that is associated mainly in men. Prostate cancer is associated with the example of illness. Usually when the damaged cells develop in the prostate gland occurs prostate cancer occurs. These cells increase uncontrollably. Reports given by the researchers show that this is most dangerous disease that is increasing in men day by day. There are different research works done by researchers using different techniques to get a solution for this major problem. As it is a dangerous disorder, medical research is trying hard to improve the prediction of prostate cancer in the field of medical diagnosis. The main aim is to improve the prediction and is still open for contribution. There are many machine learning techniques used by researchers to forecast and solve the issues in the prediction of prostate cancer. This paper approached these challenges by using a new technique in the machine learning boosting techniques by using the algorithm xg boost when compared to the previous algorithms such as support vector machines, random forest, Ada boosting, etc. to predict prostate cancer in men. We assessed our developed model's performance using accuracy as the performance metric, and our findings revealed a predictive accuracy of 99.99%, representing a notable enhancement compared to existing systems.
Keywords
References
Oyewo OA, Boyinbode OK. Prediction of prostate cancer using ensemble of machine learning techniques. Int J Adv Computer Sci Appl. 2020; 11 (3): 149–154.
Xiao LH, Chen PR, Gou ZP, Li YZ, Li M, Xiang LC, Feng P. Prostate cancer prediction using the random forest algorithm that takes into account transrectal ultrasound findings, age, and serum levels of prostate-specific antigen. Asian J Androl. 2017; 19 (5): 586–590.
Barlow H, Mao S, Khushi M. Predicting high-risk prostate cancer using machine learning methods. Data. 2019; 4 (3): 129.
Mohamed SS, Salama MM. Computer-aided diagnosis for prostate cancer using support vector machine. Proc SPIE Medical Imaging 2005: Visualization, Image-Guided Procedures, and Display. 2005; 5744: 898–906.
Li J, Weng Z, Xu H, Zhang Z, Miao H, Chen W, Liu Z, Zhang X, Wang M, Xu X, Ye Q. Support vector machines (SVM) classification of prostate cancer Gleason score in central gland using multiparametric magnetic resonance images: a cross-validated study. Eur J Radiol. 2018; 98: 61–67.
Hussain L, Ahmed A, Saeed S, Rathore S, Awan IA, Shah SA, Majid A, Idris A,Awan AA. Prostate cancer detection using machine learning techniques by employing combination of features extracting strategies. Cancer Biomark. 2018; 21 (2): 393–413.
Bhattacharjee S, Park H-G, Kim C-H, Prakash D, Madusanka N, So J-H, Cho N-H, Choi H-K. Quantitative analysis of benign and malignant tumors in histopathology: predicting prostate cancer grading using SVM. Appl Sci. 2019; 9 (15): 2969.
Wang G, Lu J, Teoh JY-C, Choi K-S. Computer aided diagnostic tool for prostate cancer with rule extraction from support vector machines. In: Liu J, Lu J, Xu Y, Martinez L, Kerre EE, editors. Data Science and Knowledge Engineering for Sensing Decision Support. Proceedings of the 13th International FLINS Conference (FLINS 2018). Singapore: Word Scientific; 2018. pp. 1315–1322.
Merriel SWD, Funston G, Hamilton W. Prostate cancer in primary care. Adv Ther. 2018; 35 (9): 1285–1294.
Peterson LE, Ozen M, Erdem H, Amini A, Gomez L, Nelson CC, Ittmann M. Artificial neural network analysis of DNA microarraybased prostate cancer ecurrence. In: 2005 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology, La Jolla, CA, USA, November 15, 2005. pp. 1–8.
Iizuka N, Oka M, Yamada-Okabe H, Nishida M, Maeda Y, Mori N, Takao T, Tamesa T, Tangoku A, Tabuchi H, Hamada K, Nakayama H, Ishitsuka H, Miyamoto T, Hirabayashi A, Uchimura S, Hamamoto Y. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet. 2003; 361 (9361): 923–929.
Zhao H, Qi S, Dong Q. Predicting prostate cancer progression with penalized logistic regression model based on co-expressed genes. In: 5th International Conference on BioMedical Engineering and Informatics, Chingqing, China, October 16–18, 2012. pp. 976–980.
Gülkesen KH, Köksal IT, Özdem S, Saka O. Prediction of prostate cancer using decision tree algorithm. Turk J Med Sci. 2009; 40: 681–686.
Ge P, Gao F, Chen G. Predictive models for prostate cancer based on logistic regression and artificial neural network. in IEEE International Conference on Mechatronics and Automation (ICMA), Beijing, China, August 2–5, 2015. pp. 1472–1477.
Takeuchi T, Hattori-Kato M, Okuno Y, Iwai S, Mikami K. “Prediction of1prostate cancer by deep learning with multilayer artificial neural network. Can Urol Assoc J. 2019; 13 (5): E145–E150.
Loeb S, Sanda MG, Broyles DL, Shin SS, Bangma CH, Wei JT, Partin AW, Klee GG, Slawin KM, Marks LS, van Schaik RH, Chan DW, Sokoll LJ, Cruz AB, Mizrahi IA, Catalona WJ. The prostate health index selectively identifies clinically significant prostate cancer. J Urol. 2015; 193 (4):
–1169.
Fossati N, Buffi NM, Haese A, Stephan C, Larcher A, McNicholas T, de la Taille A, Freschi M, Lughezzani G, Abrate A, Bini V, Palou Redorta J, Graefen M, Guazzoni G, Lazzeri M. Preoperative prostate-specific antigen isoform p2PSA and its derivatives; %p2PSA and prostate health index; predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer: results from a multicentric European prospective study. Eur Urol. 2015; 68 (1): 132–138.
Stephan C, Kahrs AM, Cammann H, Lein M, Schrader M, Deger S, Miller K, Jung K. A [−2]proPSA-based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases. Prostate. 2009; 69: 198–207.
Heijnsdijk EA, Denham D, de Koning HJ. The cost-efectiveness of prostate cancer detection with the use of prostate health index. Value Health. 2016; 19: 153–157.
Win SL, Htike ZZ, Yusof F, Batchanoor IA. Usage of machine learning in prediction of cancer recurrence. Int J Comput Sci Inform Technol. 2014; 2 (2): 11–20.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J Clin. 2006; 56: 106–130.
Akinremi TO, Adeniyi A, Olutunde A, Oduniyi A, Ogo CN. Need for and relevance of prostate cancer screening in Nigeria. Ecancermedicalscience. 2014; 8: 457.
Alexandratou E, Atlamazoglou V, Thireou T, Yova D. Evaluation of machine learning techniques for prostate cancer diagnosis and Gleason grading. Int J Comput Intell Syst Biol. 2010; 1 (3):
–315.
Leydon P, Sullivan F, Jamaluddin F, Woulfe P, Greene D, Curran KM. Machine learning in prediction of prostate brachytherapy rectal dose classes at day 30. In: Proceedings of the 17th Irish Machine Vision and Image Processing Conference, Dublin, Ireland, August 26–28, 2015.
pp. 105–109.
Gao M, Bridgman P, Kumar S. Computer aided prostate cancer diagnosis using image enhancement and JPEG2000. Proc SPIE. 2003; 5203: 323–334.
Bostwick DG, Eble JN. Urologic Surgical Pathology. St Louis, MO, USA: Mosby Year Book; 1997.
Saidi O, Cordon-Cardo C, Costa J. Technology insight: will systems pathology replace the pathologist. Nat Clin Pract Urol. 2007; 4: 39–45.
Ernest OE, Awodele O, Ebiesuwa O. Early detection and diagnosis of prostate cancer using artificial intelligence concept. Int J Comput Appl. 2016; 149 (6): 42–46.
Ige AO, Akingbesote AO, Orogun AO. Trust e-market environment: a review. Can Open Inform Sci Internet Technol J. 2019; 1 (1): 1–9.
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Journal of Computer Technology & Applications